Journal Mobile Options
Table of Contents
Vol. 3, No. 1, 2008
Issue release date: March 2008
Section title: Original Article · Originalarbeit
Free Access
Breast Care 2008;3:37–41

Delay in Seeking Medical Advice and Late Presentation of Female Breast Cancer Patients in Most of the World. Could We Make Changes? The Experience of 23 Years in Port Said, Egypt

Elzawawy A.M.a, b, c, d · Elbahaie A.M.a, b, c · Dawood S.M.c · Elbahaie H.M.a · Badran A.e
a Faculty of Medicine, Suez Canal University, Ismailia, bAlsoliman Radiation Oncology Unit, c Early Detection and Cancer Chemotherapy Unit, Port Said General Hospital, dInsurance Hospital, Port Said, e NCI, Cairo, Egypt

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.


Background: In the low and middle income countries delays in seeking consultation, late presentation, and the availability of breast cancer management for all patients, represent major challenges. Materials and Methods: The delay in seeking medical advice and the pathological tumor size of females breast cancer patients in the years 2004–2006 in Port Said, Egypt were studied and compared with previous studies by Elzawawy published since 1987. We report the progress of availability of breast cancer management from 1984 until the end of June 2007. Results: There was a decline in advanced cases. Mean time from a symptom to seeking advice was 18, 8, 3, and 1 month respectively in 1987, 1989, 1999, and 2007. Since 1984, facilities for all lines of comprehensive management have been established, interconnected, and been made accessible for all citizens, free of charge. Conclusion: Breast cancer problems are characterized by a certain multi-complexity. There is no one single cause for late cases. However, we report that the availability of cancer management facilities could lead to earlier presentation. Early detection programs would be frustrating for both patients and health authorities if patients were unable to afford accessible treatment.

© 2008 S. Karger AG, Basel


Author Contacts

Prof. Dr. Ahmed Elzawawy, MD, President of ICEDOC and Director of SEMCO, Borg Alsafwa, 3 Algeish St., 42111 Port Said, Egypt, Tel. +20-105140065, Fax -663320403, E-mail


Article Information

Published online: February 22, 2008
Number of Print Pages : 5
Number of Figures : 2, Number of Tables : 0, Number of References : 21


Publication Details

Breast Care (Multidisciplinary Journal for Research, Diagnosis and Therapy)

Vol. 3, No. 1, Year 2008 (Cover Date: March 2008)

Journal Editor: Harbeck N. (München), Jakesz R. (Wien), Thomssen C. (Halle/Saale)
ISSN: 1661–3791 (Print), eISSN: 1661–3805 (Online)

For additional information:

Article / Publication Details

First-Page Preview
Abstract of Original Article · Originalarbeit

Published online: 2/22/2008
Issue release date: March 2008

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 0

ISSN: 1661-3791 (Print)
eISSN: 1661-3805 (Online)

For additional information:

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.